Vedolizumab

≥99%, 4.89 mg/mL in PBS

Reagent Code: #245166
fingerprint
CAS Number 943609-66-3
bubble_chart
Properties This product is sold at the weight of dry products

science Other reagents with same CAS 943609-66-3

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 146814.9 g/mol
inventory_2 Storage & Handling
Storage -20°C

description Product Description

Used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. It works by targeting and blocking inflammation in the gut, reducing symptoms like diarrhea, abdominal pain, and rectal bleeding. Helps patients achieve and maintain remission, meaning fewer flare-ups and improved quality of life. Administered through intravenous infusion, it is typically used when other treatments have not worked well. Because it acts mainly in the gastrointestinal tract, it has a lower risk of affecting the immune system throughout the whole body, reducing the chance of widespread infections.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 1mg
10-20 days ฿73,000.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Vedolizumab
No image available
Used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. It works by targeting and blocking inflammation in the gut, reducing symptoms like diarrhea, abdominal pain, and rectal bleeding. Helps patients achieve and maintain remission, meaning fewer flare-ups and improved quality of life. Administered through intravenous infusion, it is typically used when other treatments have not worked well. Because it acts mainly in the gastrointestinal tract, it has a lower risk of affecting the immune system throughout the whole body, reducing the chance of widespread infections.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...